The non-hospital-based point-of-care diagnostic products industry is expected to grow from US$ 12.9 billion in 2022 to US$ 33.6 billion by 2032, at a CAGR of 9.1 % during the forecast period. This growth is attributed to a number of factors, including the rising prevalence of chronic diseases, increasing demand for home healthcare, and technological …
Category Archives: Healthcare Trends
Point Of Care Blood Testing Devices Industry is on track to achieve a valuation of US$ 49,973.6 Million by 2032 | FMI
By 2032, the Point of care blood testing devices industry Size is anticipated to be worth US$ 49,973.6 million, up from US$ 15,362.4 million in 2022, growing at a CAGR of 11.3%. Point of care or POC blood testing devices are easy handheld devices which are used to perform various blood tests. Point of care blood testing …
Multiplex Molecular Diagnostics Industry is expected to achieve a worth of US$ 39.25 Billion by 2032, as per FMI
The global multiplex molecular diagnostics market is expected to reach US$ 23.2 Billion in 2022, and to US$ 39.25 Billion by 2032, growing at a CAGR of 5.4% from 2022 to 2032. The market growth is attributed to factors such as increasing prevalence of infectious diseases, rising demand for personalized medicine, and technological advancements in …
Spinal Surgery Neuro Monitoring System Industry is anticipated to achieve a 6.8% CAGR by 2032, as reported by FMI
A method called the Neuro monitoring system devices industry is intended to lower the risk of neurological abnormalities following operations on the nervous system. As it records the nervous system’s electrical potentials during surgery, the neuro monitoring system has developed. The chances of paralysis, hearing loss, and muscle weakness have decreased since the development of …
Cytogenetic Systems Industry is forecasted to secure a value of US$ 5,327.8 Million by 2032 | FMI
Global Cytogenetic systems industry demand is anticipated to be valued at US$ 1,688.5 Million in 2022, forecast to grow at a CAGR of 11.0% to be valued at US$ 5,327.8 Million from 2022 to 2032. Growth is attributed to the increase in incidence of genetic disorders and cancer. The major techniques of cytogenetic testing include fluorescence in-situ hybridization, multiplex-fluorescence in situ hybridization, comparative …
Oncology Blood Testing Industry is poised for success, expected to generate US$ 18,278.2 Million by 2032, according to FMI
The Oncology blood testing industry refers to the market for diagnostic tests that analyze blood samples to detect and monitor various types of cancers. These tests are used to identify specific biomarkers or genetic alterations associated with cancer, aiding in early detection, treatment selection, and monitoring of the disease. The market for oncology blood testing …
Non-Hyaluronic Acid dermal fillers Market are in demand for their longer-lasting results, propelling the to US$ 520.4 million by 2032 | FMI
By 2032, it is anticipated that the non-hyaluronic acid dermal filler market will be worth US$ 520.4 million. The global non-hyaluronic acid dermal filler market is anticipated to reach US$ 392.7 Million in 2022 and is expected to grow at a CAGR of 2.6% from 2022 to 2032, according to FMI Analysts. Hyaluronic acid (HA) …
Global Stoma Ostomy Care Industry Set to Soar to US$6.5 Billion by 2033, with a CAGR of 4.9% | FMI
The global industry for stoma ostomy care is poised for an impressive surge, with a projected value of US$3.8 billion by the end of 2022 and an estimated compound annual growth rate (CAGR) of 4.9% throughout the forecast period from 2023 to 2033. This substantial growth trend positions the market to reach an approximate value …
Global Peptide Synthesis Industry Aiming for US$1.1 Billion Valuation by 2033 at an Impressive 8% CAGR, | FMI Reports
The Global Peptide Synthesis Industry is on a trajectory of exponential growth, with projections indicating it will achieve a valuation of US$1.1 billion by 2033. In 2023, the market is expected to reach US$520.0 million, driven by a strong Compound Annual Growth Rate (CAGR) of 8% during the forecast period. The burgeoning demand for peptide …
Global Medical Rehabilitation Robotics Industry to Surge at 15.2% CAGR, Reaching US$1.76 Billion by 2033 | FMI’s Insight
The Global Medical Rehabilitation Robotics Industry is poised for an extraordinary surge, with a projected Compound Annual Growth Rate (CAGR) of 15.2%. By 2033, the market is expected to reach a remarkable valuation of US$ 1.76 Billion, a substantial increase from the US$ 366.2 Million recorded in 2022. The Pediatrics Rehabilitation Robotics Market, a sector …